Sideroblastic anemia screening

Revision as of 14:23, 10 August 2018 by Nazia Fuad (talk | contribs) (→‎Overview)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Sideroblastic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sideroblastic Anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sideroblastic anemia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sideroblastic anemia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sideroblastic anemia screening

CDC on Sideroblastic anemia screening

Sideroblastic anemia screening in the news

Blogs on Sideroblastic anemia screening

Directions to Hospitals Treating Sideroblastic anemia

Risk calculators and risk factors for Sideroblastic anemia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nazia Fuad M.D.


Overview

According to The National Center for Biotechnology Information NCBI, screening for sideroblastic anemia by using one of the tests, mitochondrial focused nuclear gene panel, congenital sideroblastic anemia panel and PUS1 gene sequencing is available for, molecular confirmation of genetic sideroblastic anemia, testing of patients with positive family history of sideroblastic anemia and prenatal diagnosis for gene mutation in at-risk pregnancies.

Screening

Tests name

According to the National Center for Biotechnology Information center, the following tests are available for screening sideroblastic anemia:[1][2]

  • Mitochondrial focused nuclear gene panel
  • Congenital sideroblastic anemia panel
  • PUS1 gene sequencing

Clinical utility

  • Molecular confirmation of genetic sideroblastic anemia
  • Testing of patients with positive family history of sideroblastic anemia
  • Prenatal diagnosis for gene mutation in at-risk pregnancies.

References

  1. Koenig MK (May 2008). "Presentation and diagnosis of mitochondrial disorders in children". Pediatr. Neurol. 38 (5): 305–13. doi:10.1016/j.pediatrneurol.2007.12.001. PMC 3099432. PMID 18410845.
  2. Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, Smertenko T, Alston CL, Neeve VC, Best A, Yarham JW, Kirschner J, Schara U, Talim B, Topaloglu H, Baric I, Holinski-Feder E, Abicht A, Czermin B, Kleinle S, Morris AA, Vassallo G, Gorman GS, Ramesh V, Turnbull DM, Santibanez-Koref M, McFarland R, Horvath R, Chinnery PF (July 2014). "Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies". JAMA. 312 (1): 68–77. doi:10.1001/jama.2014.7184. PMID 25058219.

Template:WS Template:WH